Tcg Crossover Management, LLCFirm match from fund name (lower confidence)
TCG Crossover Fund I, L.P.
Follow-ons onlyEmerging manager
Follow-ons only: first sale Jan 2021, per Form D (fund age approximates vintage)
- Vintage
- 2021
- Fund size
- $800M (Form D)
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Sectors
- Biotech
- Regions
- Global
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$5.33M to $10M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Chen Yu, Managing Member of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideTCG Crossover (“TCGX”) is an investment firm focused on innovative biotech companies that invests in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.
We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.
https://tcgcrossover.com/about-us/
06 · Sources
Last verified: Oct 28, 2026